pioglitazone has been researched along with Osteoporosis, Postmenopausal in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samadfam, R | 1 |
| Awori, M | 1 |
| Bénardeau, A | 1 |
| Bauss, F | 1 |
| Sebokova, E | 1 |
| Wright, M | 1 |
| Smith, SY | 1 |
| Eckert, S | 1 |
| Erdmann, E | 1 |
| Lundershausen, R | 1 |
| Forst, T | 1 |
| Scherbaum, WA | 1 |
| Schnell, O | 1 |
| Standl, E | 1 |
| Schumm-Draeger, PM | 1 |
| Tschöpe, D | 1 |
| Walter, H | 1 |
| Weber, M | 1 |
2 other studies available for pioglitazone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Topics: Adiposity; Animals; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone | 2012 |
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes].
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Fractures, Bone; Glycate | 2007 |